These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35899493)

  • 1. Role of the PD-1 and PD-L1 axis in COVID-19.
    R Bonam S; Hu H; Bayry J
    Future Microbiol; 2022 Sep; 17():985-988. PubMed ID: 35899493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 Dysregulation in COVID-19 Patients.
    Sabbatino F; Conti V; Franci G; Sellitto C; Manzo V; Pagliano P; De Bellis E; Masullo A; Salzano FA; Caputo A; Peluso I; Zeppa P; Scognamiglio G; Greco G; Zannella C; Ciccarelli M; Cicala C; Vecchione C; Filippelli A; Pepe S
    Front Immunol; 2021; 12():695242. PubMed ID: 34163490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity.
    Niedźwiedzka-Rystwej P; Majchrzak A; Aksak-Wąs B; Serwin K; Czajkowski Z; Grywalska E; Korona-Głowniak I; Roliński J; Parczewski M
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity.
    Beserra DR; Alberca RW; Branco ACCC; de Mendonça Oliveira L; de Souza Andrade MM; Gozzi-Silva SC; Teixeira FME; Yendo TM; da Silva Duarte AJ; Sato MN
    J Immunol Res; 2022; 2022():9764002. PubMed ID: 35971391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.
    Aghbash PS; Eslami N; Shamekh A; Entezari-Maleki T; Baghi HB
    Life Sci; 2021 Apr; 270():119124. PubMed ID: 33508291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection.
    Rutigliani M; Bozzo M; Barberis A; Greppi M; Anelli E; Castellaro L; Bonsignore A; Azzinnaro A; Pesce S; Filauro M; Rollandi GA; Castagnola P; Candiani S; Marcenaro E
    Front Immunol; 2022; 13():849140. PubMed ID: 35222440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delicate Role of PD-L1/PD-1 Axis in Blood Vessel Inflammatory Diseases: Current Insight and Future Significance.
    Veluswamy P; Wacker M; Scherner M; Wippermann J
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives.
    Mocan T; Sparchez Z; Craciun R; Bora CN; Leucuta DC
    Clin Transl Oncol; 2019 Jun; 21(6):702-712. PubMed ID: 30387047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics.
    Cassol CA; Owen D; Kendra K; Braga JR; Frankel WL; Arnold CA
    Histopathology; 2020 Aug; 77(2):240-249. PubMed ID: 32298485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint.
    Wang Q; Lin W; Tang X; Li S; Guo L; Lin Y; Kwok HF
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
    Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
    Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1/PD-1 axis as a potent therapeutic target in breast cancer.
    Bastaki S; Irandoust M; Ahmadi A; Hojjat-Farsangi M; Ambrose P; Hallaj S; Edalati M; Ghalamfarsa G; Azizi G; Yousefi M; Chalajour H; Jadidi-Niaragh F
    Life Sci; 2020 Apr; 247():117437. PubMed ID: 32070710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
    Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
    Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes.
    Falcone M; Fousteri G
    Front Endocrinol (Lausanne); 2020; 11():569. PubMed ID: 32973682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
    Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
    Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-1/PD-L1 axis in organ fibrosis.
    Zhao Y; Qu Y; Hao C; Yao W
    Front Immunol; 2023; 14():1145682. PubMed ID: 37275876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD1/PD-L1 Expressions in Plasmablastic Lymphoma with Clinicopathological Correlation.
    Rosado FG; Coberly J; Gupta A; John G; Naina H; Koduru P; Chen W
    Ann Clin Lab Sci; 2021 Mar; 51(2):174-181. PubMed ID: 33941556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.
    Xie M; Huang X; Ye X; Qian W
    Int Immunopharmacol; 2019 Dec; 77():105999. PubMed ID: 31704289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
    Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
    Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
    Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.